טוען...

RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma

The present study was designed to investigate the association between response evaluation criteria in solid tumors (RECIST) 1.1 and 1.0, and to explore the utility of thyroglobulin (Tg) measurements in assessing tumor responses to sorafenib in patients with radioactive iodine (RAI)-refractory differ...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: RUAN, MAOMEI, SHEN, YAN, CHEN, LIBO, LI, MINGHUA
פורמט: Artigo
שפה:Inglês
יצא לאור: D.A. Spandidos 2013
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3789091/
https://ncbi.nlm.nih.gov/pubmed/24137351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2013.1424
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!